420 with CNW – First Cannabis Charity Launches in Canada

Hope for Health, a Toronto-based charity, has been launched as the first cannabis charity registered by the Canadian government. The charity is registered in the category of organizations whose intention is the “advancement of education.”

Hope for Health says it aims to enable patients to manage their health effectively while also giving them the autonomy to choose which cannabis products and cannabis producers to deal with.

The charity kick-started its operations amidst fears that medical marijuana patients are getting reduced attention as more attention is directed towards the recreational market. This is seen in the rising medical marijuana product prices. Access points for medical cannabis are also reducing while a new excise tax on marijuana prices has also been imposed on medical marijuana products. This excise tax can only be waived on the product price if the company selling medical marijuana products opts to absorb that cost.

To alleviate this increased cost of medical marijuana products, Hope for Health has decided to avail a renewable monthly stipend to patients who meet the eligibility criteria of the charity. This stipend is conditioned upon the patient purchasing their medical marijuana products from one of the 170 producers licensed by the Canadian federal government.

Hope for Health intends to take on at least 150 patients during its first year of operation. More patients will be onboarded each year and the number will vary depending on the resources available as well as the level of interest displayed by patients.

The charity doesn’t only have its eyes on patients. Hope for Health plans to create and disseminate educational materials to health care professionals about the medicinal benefits of marijuana. This will be done in conjunction with creating partnerships with research organizations, academic institutions and medical associations.

Hope for Charity is the brainchild of Auxly Cannabis Group, an entity that provides financing to cannabis cultivators. Auxly Cannabis Group has committed itself to availing funding that they are calling “a cornerstone donation.” The funds will be used to get the charity on its feet.

Hugo Alves, the director of Hope for Health, remarked that the idea of the charity was conceived three years ago. The founders felt that every entity which had reaped from the cannabis industry in the country would rally around the idea and support its operations.

The founders also strongly felt that the leadership and management of the charity should be independent if Hope for Health is to retain its appeal to all players in the industry. To this end, they selected Dr. Jenna Valleriana as the Executive Director of the charity.

Dr. Valleriana is a respected cannabis policy expert who heads the National Institute for Cannabis Health and Education. She recently published a cannabis education toolkit which was used by two other organizations to design digital tools aimed at educating students and parents about marijuana.

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) and Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) commend the people behind Hope for Health and wish them all the best in their noble undertaking.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Missouri Puts Final Touches to Medical Marijuana Rules

Voters in Missouri approved a ballot measure which legalized medical marijuana in 2018. In March this year, the Department of Health and Senior Services released draft rules for the medical marijuana program and invited public comment on those rules. Last week, the department completed making changes to the draft rules based on the feedback received and they published the revised draft rules on the department’s website on Friday.

The rules cover 11 broad aspects of the medical cannabis program. These include rules covering patients and caregivers participating in the program, cultivation facility license procedures and requirements, testing facilities, seed to sale marijuana tracking and the rules governing medical marijuana manufacturing facilities.

The Department of Health and Senior Services (DHSS) will start receiving patient applications based on these rules on July 4 while applications from businesses which want licenses will be received starting August 3. The application forms are now available on the website and all interested parties can access and fill those forms.

DHSS will then start scoring the business applications and complete this exercise on December 31 this year, after which business licenses will be issued to the successful applicants in 2020.

The medical marijuana program has attracted a lot of interest from the business community, and the state expects to generate millions of dollars in taxes and fees from the industry.

However, the actual earnings are likely to fall short of what has been predicted. Economics professors at Missouri University crunched the numbers and concluded that the number of eligible patients in the state would be less than initially expected. The professors estimated that in 2022, the medical marijuana program is likely to raise about $3.4 million in taxes and fees, a figure which is much lower than the $24 million predicted by the people behind the initiative which saw the approval of the ballot measure legalizing medical marijuana.

In the meantime, 510 applications have been pre-filled and are due to be submitted. Those applications have generated more than $3.67 million in application fees. From these applications, 60 cultivation facilities, 86 manufacturing facilities and 192 medical marijuana dispensaries will be selected. The state will license 24 dispensaries for each of the eight congressional districts.

These draft rules will also be subject to public comment and a public hearing will be organized in July. TransCanna Holdings Inc. (CSE: TCAN) and Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) applaud the authorities in Missouri for systematically implementing the roadmap to the commercialization of the medical marijuana program.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Hunt for Perfect Acquisitions Reshapes Cannabis Industry

CannabisNewsWire Editorial Coverage: Cannabis companies are using increasingly refined acquisition tactics to create vertical integration.

TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) (TCAN Profile) has developed a refined acquisition strategy, assessing more than one hundred targets before settling on a select few to acquire. Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF), one of America’s leading multistate cannabis companies, has recently announced its agreement to acquire CannaRoyalty Corp. (OTCQX: ORHOF), giving it control over a vast distribution platform. In Canada, HEXO Corp. (TSX: HEXO) (NYSE American: HEXO) has been given approval to acquire Newstrike, as the country’s vibrant industry consolidates following recent dramatic growth. For those without vertical integration, companies such as DionyMed Brands Inc. (CSE: DYME) (OTCQB: DYMEF) provide vital support services, including…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – State Statistics Reveal Less than 50 Percent of Ohio Patients Have Purchased Medical Marijuana

Medical marijuana was legalized in Ohio in 2016 and sales only started this year. Figures coming in from the state show that only 15,339 of the patients who hold medical marijuana cards have so far visited a dispensary and purchased medicinal marijuana products. Several factors can explain why just 49 percent of the cardholders have bought medical marijuana.

First, very few medical marijuana dispensaries have opened their doors to patients. Out of 56 dispensary licenses which were issued, just a paltry 15 establishments have started operating. These few dispensaries aren’t evenly distributed across the state, and this may explain why few patients have visited them and bought products.

Secondly, the price of the available products is still too high for many patients. The high prices may be resulting from the limited competition between the few dispensaries which have opened. Additionally, not many growers and processors are currently operating in the state. Prices are expected to reduce as more growers and processors come on board to supply the dispensaries in the state.

The state agencies involved in regulating the medical marijuana program also released other statistics related to the program.

For example, out of the 31,075 patients registered on the medical marijuana program, 171 have a diagnosis for a terminal illness, such as cancer. This could suggest that these people are taking medical marijuana to deal with pain.

The medical marijuana register also has 2,109 people registered as caregivers. Caregivers buy and administer medical cannabis to minors or people whose illness is so severe that they cannot buy and administer the medical marijuana by themselves.

In terms of sales, $5.8 million has been recorded as the revenue earned by medical marijuana businesses in the first four months of 2019. This is way below the potential of the industry since Ohio is ranked 7th in the country in terms of its population and GDP.

In total, 750 pounds of marijuana plant material were sold by the medical cannabis dispensaries in the past four months. 3,610 units of manufactured cannabis products, such as oils and tinctures, were also sold.

Larger volumes of products are expected to be sold as medical marijuana becomes more readily available and as more people qualify for medical cannabis cards after more qualifying conditions were added to the initial list of 21 qualifying conditions.

TransCanna Holdings Inc. (CSE: TCAN) and Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) encourage all the entities that have received medical cannabis licenses to start operations quickly so that they can contribute to the growth of the medical marijuana industry in Ohio.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Full-Spectrum Seed-to-Sale Model, Quality Branding Key to Cannabis Success

CannabisNewsWire Editorial Coverage: Last year was a year of maturation for the cannabis market.

  • California’s growing pains are a recipe for success for handful of savvy operators
  • Brands, consistency and scalability likely deciding factors for many companies
  • Projected global market size an open-and-shut case for scaling up NA sector

The market growth resulted from retailers in nine legal adult-use states being pushed beyond the sector’s historically core demographics, targeting fast-growing new segments such as women, with an emphasis on elements such as wellness and clearly labeled/low-dose alternatives. That trend was reinforced with CBD breaking out into the mainstream, as industrial hemp became legal throughout the United States, and cannabis companies looked for ways to stand out from the crowd. Some companies were more successful at this than others, with TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) (TCAN Profile) making huge strides recently to expand the upper-end procurement part of the business, as well as flesh-out its footprint of branded offerings. Other moves have been made by comparable sector players such as Canopy Growth Corporation (NYSE: CGC) (TSX: WEED), DionyMed Brands Inc. (OTCQB: DYMEF) (CSE: DYME), Cresco Labs Inc. (OTCQX: CRLBF) (CSE: CL) and CannaRoyalty Corp. (OTCQX: ORHOF) (CSE: OH), which are pursuing similarly comprehensive approaches to the sector that run the gamut from…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – New Hampshire Senate Okays Medical Marijuana Home Cultivation

House Bill 364, a proposed law that seeks to allow patients taking medical cannabis to grow marijuana at home, has been approved by the senate in New Hampshire. The vote was close, but the bill sailed through 14-10.

Under the proposed legislation, patients who have been enrolled on the medical marijuana program of the state can have 12 medical marijuana seedlings, 3 young plants and 3 mature plants for their own use.

Currently, New Hampshire has 7,000 registered patients in the medical cannabis program. These patients have been compelled to get all their medical marijuana from just four Alternative Treatment Centers operating in the state.

The small number of retail outlets has resulted in high medical cannabis product prices, and many patients who cannot afford those products have resorted to using prescription opioids and other potentially harmful alternatives since medical marijuana isn’t covered by most insurance companies.

Activists have welcomed the bill saying that it will give patients a viable alternative to the expensive medical marijuana available at Alternative Treatment Centers.

There was resistance to the bill in the senate, and several changes were made in order to accommodate the concerns of the dissenting voices. For example, the bill initially had a provision which would allow a medical cannabis patient to gift marijuana to another patient who is registered to use medical cannabis in the state.

This provision was removed because there were concerns that such gifting would open the way to medical marijuana getting to the wrong people, such as criminal gangs selling marijuana on the black market.

Despite the changes, some senators, such as Sen. James Gray, are still adamant that legalizing home grows isn’t a good move. He said that the state has a rigorous system in place to make sure that the licensed cultivators only supply their products to the state-approved retailers. Allowing home grows creates a regulatory nightmare because it will be hard to monitor the plants grown by each patient who chooses to grow medical marijuana, Gray added.

Now that the bill has received senate approval, it now heads back to the House of Representatives where it had initially been approved and sent to the senate. The bill is coming back to the House so that the lawmakers there can consider the changes made by senate.

If the lawmakers in the House of Representatives pass the bill in its current form, then it will be sent to the desk of Gov. Sununu for a final decision on whether it becomes law.

TransCanna Holdings Inc. (CSE: TCAN) and Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) sympathize with the patients and call upon the authorities to pass the bill quickly so that those who cannot afford the medical cannabis in Alternative Treatment Centers can grow their own.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Epileptic Dogs Get Fewer Seizures When Given CBD Oil, Study Finds

A new study whose results were published in the journal Pet Behavior Science indicates that dogs with epilepsy have less frequent seizures if treated using CBD oil.

The study was small because it only followed three dogs over a period of two months while those dogs were treated with CBD oil. The research suggests that dogs respond to cannabis treatment in the same way that humans do.

The age and breed of the dogs studied varied. For example, one dog was a Labrador Retriever aged 3. This dog used to suffer an average of one epileptic seizure every month. A Papillion (aged 11) was also in the study. This particular dog suffered seizures every 2 or 3 months. The third dog was a Chihuahua aged 10. It usually suffered about two seizures every year.

During the study, the dogs were given CBD oil on an empty stomach twice each day. The findings released were based on the reports provided by the dog owners during the study period.

Two of those dog owners reported that their dogs improved during the time when they were given CBD oil. However, the owner of the Papillion reported that the dog didn’t exhibit any changes in its condition.

More specifically, the Labrador Retriever’s owner said that the dog barked less during the day and slept longer at night. The dog was also less excited when compared to other dogs that didn’t receive the CBD oil treatment. Overall, the owner was convinced that the dog improved after taking the CBD oil.

Similarly, the owner of the Chihuahua reported that the dog was less aggressive towards familiar people (the owner’s kids, for example) during the time when it was receiving CBD oil. The seizure-like behavior also reduced slightly during treatment.

The researchers revealed that it wasn’t clear whether CBD oil works in the same way to treat epilepsy in dogs as it does in humans. They opined that it is possible that by alleviating anxiety, CBD oil could reduce the frequency of epileptic seizures in both humans and dogs.

They called for more research to understand the neurobiological mechanisms through which CBD oil treatments triggered therapeutic effects.

There is a growing body of research showing that dogs can be treated effectively for various conditions using CBD oil. For example, one study last year found that CBD oil can trigger improvements in the symptoms of osteoarthritis in dogs.

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) and TransCanna Holdings Inc. (CSE: TCAN) urge all dog owners to use these research findings as a basis to talk to vets about alternative treatments for their dogs instead of being restricted to the conventional treatments alone.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Cumbersome UK Medical Cannabis Program Forces Parents to Resort to Smuggling

Legally, patients who qualify can access medical cannabis across the UK ever since an enabling law paved the way for this treatment to be available from November 1, 2018. However, the reality is another thing altogether as patients are made to jump endless hoops in order to access medical marijuana through the National Health Service (NHS).

The cumbersome bureaucratic system has compelled many desperate parents of kids who badly need medical marijuana to resort to smuggling the medicine from other countries.

Emma Appleby is one of those parents, and her story is heart-wrenching. She says her daughter, aged nine, suffers from severe epilepsy that causes the child to have more than 300 seizures every single day.

Appleby tried to follow the official channels in order to get her daughter on the medical cannabis that has been documented to help patients like her child. However, she got one flat “no” after another as she presented her case before various medical officials who had to approve her application before her daughter could get medical cannabis.

This rejection pushed Appleby to the edge and last week, she decided to take matters into her own hands. She travelled to the Netherlands and bought medical cannabis oil worth nearly $6,000. This was sufficient to treat her daughter for three months.

However, customs authorities seized the medicine as soon as she landed back home. She is angry that her daughter continues to suffer while the medical professionals and the NHS keep arguing about what sort of evidence is required for one to access medical marijuana.

Emma Appleby has vowed to fight until the seized medication is returned so that her child can be treated. Hers isn’t a farfetched dream, since there is a precedent on this issue.

Earlier this year, another parent, Charlotte Caldwell, also tried to smuggle medical cannabis into the UK but it was intercepted by customs. However, the medicine was quickly returned to her (in less than a week) after her sick son’s health deteriorated and he was admitted. Cannabis had been keeping the boy stable, so when he went without it as the authorities prevented his mother from treating him with the smuggled medicine then his health went downhill rapidly.

Such cases have led medical cannabis supporters in the British parliament to rise up in arms against the implementers of the medical cannabis law who have made it hard for the intended beneficiaries of that law to access badly needed treatment.

The program is so hard to navigate that only 12 patients have got licenses to receive medical cannabis since November 1 last year when the law came into effect. TransCanna Holdings Inc. (CSE: TCAN) and VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) sympathize with the parents who have been forced to try and circumnavigate the law in order to access medical cannabis. The authorities should do whatever is possible to make it easier for patients to get the treatment they need.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Cuomo Insists Recreational Weed Will Be Legal By June

When the $17 billion state budget was adopted without marijuana policy reflected in it, cannabis advocates were crestfallen because they realized that their dream of seeing marijuana legal for adult-use had just taken a major hit. However, Governor Andrew Cuomo has vowed that he will do everything possible to pass the law by June when the legislative session ends.

The Governor said that the problem wasn’t the lack of political will to pass the law. Rather, there were differing opinions regarding the way in which legalization would be implemented in the state.

Because of those differing views on implementation, it wasn’t possible to reach an agreement on the matter while getting a budget ready for adoption. Now that the budget is out of the way, Cuomo feels that his full attention can now be devoted to hammering out the details of how recreational cannabis will be taxed, regulated and social justice attained.

Many lawmakers aren’t as optimistic as the Governor regarding the chances of the bill now that it isn’t included in the budget. For example, State Sen. Diane Savino points to what happened in neighboring New Jersey where marijuana advocates thought they had a done deal but voting on the legalization bill was cancelled due to fears that not enough “yes” votes had been secured in the State Senate.

That sobering example from New Jersey shows how tough things could get in New York State now that marijuana policy wasn’t included in the state budget.

It should also be remembered that out of the 10 states and Washington, D.C. that have legalized recreational pot, only one did so by legislative means. All the other states relied on ballot measures or referenda to legalize recreational cannabis.

This statistic shows that the general populace is always ahead of the lawmakers who have the responsibility to make decisions on behalf of the people that they represent.

It is therefore going to be a great deal harder for a majority of the lawmakers in New York State to pass a standalone marijuana legalization bill.

Already, there was intense opposition even while there was a chance that marijuana legalization would be included in the state budget. For example, the leaders in two of the New York suburbs with the largest population have already indicated that the sale of recreational cannabis will not be allowed in those jurisdictions.

TransCanna Holdings Inc. (CSE: TCAN) and Vivo Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) hope that the lawmakers can put aside their political differences and put the interests of New Yorkers first when discussing the way forward on marijuana legalization.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Pennsylvania Senators Seek Cosponsors for Cannabis Legalization Bill

Two senators in Pennsylvania have drafted a bill to legalize recreational marijuana in the state, and they are now seeking cosponsors for their initiative.

State Sen. Sharif Street (D-Philadelphia) and Sen. Daylin Leach (D-Montgomery) have drafted the bill that reads like a dream come true for any marijuana advocate.

The bill intends to allow adults who are 21 or older to grow a maximum of six mature cannabis plants at home for their own use.

Home delivery of marijuana and its products will also be legal if the bill is enacted.

While it would be illegal to consume cannabis in public, the legislators included provisions that would permit the opening of marijuana consumption lounges where adults can go and indulge.

SB 350 goes further to suggest that not only will minor marijuana convictions and arrests be expunged from people’s criminal records, all individuals on similar charges who are serving time in Pennsylvania jails will be released as well. This goes far beyond what other states have done after legalizing recreational weed.

The bill also touches on where the tax revenue from recreational marijuana will be spent. Sens. Sharif and Leach propose that most of the taxes collected from the industry should go to revamping the public schools in the state.

The taxes generated may be considerable if the projected $600 million in sales for the first year materializes and increases in the subsequent years.

Some of the states that have legalized recreational marijuana have failed to invest cannabis taxes in social services because the funds went to meeting the costs of regulation and law enforcement.

The Pennsylvania Senators want to change that trend by including provisions on tax expenditure in the cannabis law so that there will be no risk of diverting the tax revenue to other expenditure areas.

Senator Sharif Street explains that the legalization of marijuana would help to address the opioid crisis in the state. He cites research data from other states showing that opioid use has reduced by about 33 percent after the legalization of medical marijuana.

While Gov. Tom Wolf is cautiously supportive of cannabis legalization, not everyone is ecstatic about the possibility.

For example, Jake Corman, the Republican Majority Leader in the Senate, says legalizing marijuana is “reckless and irresponsible.” He has gone further to vow that he will do whatever he can to stop any legalization bill from passing.

Cannabis advocates therefore have their work cut out for them if they want to see the bill become law. Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) and TransCanna Holdings Inc. (CSE: TCAN) look forward to hearing vibrant debates about the issues related to cannabis legalization before a decision is made for the good of all Pennsylvanians.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com